Legal Representation
Attorney
F. William McLaughlin
USPTO Deadlines
Next Deadline
1948 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-12)
Due Date
November 12, 2030
Grace Period Ends
May 12, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description |
|---|---|---|---|
| May 3, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Apr 11, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Apr 11, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Feb 12, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Nov 12, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Nov 12, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Aug 27, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 24, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Aug 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 7, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Aug 7, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Jul 24, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jul 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 3, 2024 | RFNT | P | REFUSAL PROCESSED BY IB |
| Apr 30, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 30, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Apr 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 29, 2024 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Apr 23, 2024 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Apr 11, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 22, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 17, 2023 | RFNT | P | REFUSAL PROCESSED BY IB |
| Sep 25, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sep 25, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Sep 6, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sep 5, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 21, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Mar 17, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 9, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
pre-filled syringes for medical purposes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical for the treatment of viral diseases, pharmaceutical for infusions, pharmaceutical for injections, diluents, emergency pharmaceuticals, active pharmaceutical ingredients; syringes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; syringes sold filled with pharmaceutical for the treatment of viral diseases, pharmaceutical for infusions, pharmaceutical for injections, diluents, emergency pharmaceuticals, active pharmaceutical ingredients
Class 010
Dental syringes; syringes for medical purposes; medical syringe needles; Medical syringes for injections; medical syringes in the form of pens; Medical insulin syringes in the nature of insulin pens sold empty; disposable nozzles for dental syringes; disposable needles for medical hypodermic syringes; syringes for dental purposes; nozzles for dental syringes; injection syringes for cosmetic surgery; disposable medical syringes for aesthetic treatments; medical venom extraction syringes; hypodermic syringes for use in administering injection substances; medical spinal syringes; medical fluid injectors for medical purposes; hypodermic needles; hypodermic injection apparatus; injection instruments without needles; injection device for pharmaceuticals; injection needles for medical use; injection sleeves for medical use; hypodermic syringes for injections for medical purposes; disposable syringes; disposable hypodermic syringes for surgical use; disposable hypodermic syringes for medical use; cannulae; tubing for use with cannulas; surgical apparatus and instruments; surgical apparatus and instruments for dental use; surgical apparatus and instruments for medical use
Classification
International Classes
005
010
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO